Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation

Liver International

Volumn 27, Issue 7, 2007, Pages 930-937

  Martínez López, Erika ^a   Nuño González, Patricia ^a   Ruiz Madrigal, Bertha ^a   Rodríguez Sancho, Luis Carlos ^a   Hernández Nazará, Zamira H ^a   Segura Ortega, Jorge Enrique ^a   Panduro, Arturo ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Apolipoprotein AI; Apolipoprotein E; HDL c; Liver damage; mRNA expression; Orthotopic liver tranplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LEUKOCYTE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER CIRRHOSIS; LIVER INJURY; LIVER TRANSPLANTATION; MALE; ORTHOTOPIC TRANSPLANTATION; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALKALINE PHOSPHATASE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547924112     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01509.x     Document Type: Article

References (31)

1. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci 1998; 33: 1601-14.
2. Clermont RJ, Chalmers TC. The transaminase test in liver disease. Medicine (Baltimore) 1967; 46: 197-207.
3. Herrera JL. Abnormal liver enzyme levels. QCME Postgrad Med 1993; 93: 113-6.
4. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: A guide for clinicians. CMAJ 2005; 172: 367-79.
5. Schönfeld JV, Erhard J, Beste M, et al. Conventional and quantitative liver function tests after hepatic transplantation: A prospective long term follow-up. Transpl Int 1997; 10: 212-6.
6. Merkel C, Gatta A, Zoli M, et al. Prognostic value of galactose elimination capacity, aminopyrine breat test and ICG clearance in patients with cirrhosis. Dig Dis Sci 1991; 36: 1197-203.
7. Chouker A, Martignoni A, Schauer RJ, et al. Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World J Surg 2005; 29: 528-34.
8. Oellerich M, Burdelski M, Ringe B, et al. Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet 1989; 1: 640-2.
9. Zotz RB, Schönfeld JV, Erhard J, et al. Value of an extended MEGX formation test and other dynamic liver function test in liver transplant donors. Transplantation 1997; 63: 538-41.
10. Malmendier CL, Lontie JF, Mathe D, Adam R, Bismuth H. Lipid and apolipoprotein changes after orthotopic liver transplantation for end-stage liver diseases. Clin Chem Act 1992; 209: 169-77.
11. Katsuramaki T, Hirata K, Kimura Y, et al. Changes in serum levels of apolipoprotein A-I as an indicator of protein metabolism after hepatectomy. Wound Repair Regen 2002; 10: 77-82.
12. Panduro A, Shalaby F, Shafritz DA. Changing patterns of transcriptional and post-transcriptional control of liver specific gene expression during rat development. Genes Dev 1987; 1: 1172-82.
13. Panduro A, Lin-Lee Y, Chan L, Shafritz DA. Transcriptional and posttranscriptional regulation of apolipoprotein E, AI and AII gene expression in normal rat liver and during several pathophysiologic states. Biochemistry 1990; 29: 8430-5.
14. Panduro A, Castrillón L, González L, Shafritz DA. Regulation of hepatic and non-hepatic apolipoprotein AI and E gene expression during liver regeneration. Biochim Biophys Acta 1993; 1167: 37-42.
15. Nuno-Gonzalez P, Ruiz-Madrigal B, Bastidas-Ramirez BE, Martinez-Lopez E, Segura JE, Panduro A. Expression of apolipoprotein AI mRNA in peripheral white blood cells of patients with alcoholic liver disease. Biochim Biophys Acta 2005; 1740: 350-6.
16. Smith DL, Rommel F. A rapid micromethod for the stimulation of phagocytic-microbicidal activity of human peripheral blood leukocytes. J Immunol Methods 1977; 17: 241-7.
17. Mathurin P, Vidaud D, Vidaud M, et al. Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease. Hepatology 1996; 23: 44-51.
18. Rosen HR, Martin P, Donovan J, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998; 65: 68-72.
19. Habib A, Mihas AA, Abou-Assi SG, et al. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin Gastroenterol Hepatol 2005; 3: 286-91.
20. Dalton MB, Swaney JB. Structural and functional domains of apolipoprotein A-I within high density lipoproteins. J Biol Chem 1993; 268: 19274-83.
21. Zannis VI, Cole FS, Jackson CL, Kurnit DM, Karathanasis SK. Distribution of Apolipoprotein A-I, CII, CIII and E mRNA in fetal human tissues, time-depending induction of apolipoprotein E by cultures of human monocyte-macrophages. Biochemistry 1985; 24: 4450-5.
22. Byones L, Luo CC, Li WH, Yang CY, Chan L. Chicken apolipoprotein A-I: cDNA sequence tissue expression and evolution. Biochem Biophys Res Commun 1987; 148: 485-92.
23. Ferrari S, Drusiani E, Calandra S, Tarugi P. Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and it's use for detecting apo-AI mRNA expression in several chick tissues. Gene 1986; 42: 209-14.
24. Harr SP, Uint L, Hollister R, Hyman BT, Mendez AI. Brain expression of apolipoproteins E, J and A-I in Alzheimer's disease. J Neurochem 1996; 66: 2429-35.
25. Blue ML, Ostapchuk P, Gordon JS, Williams DI. Synthesis of apolipoprotein AI by peripheral tissues of the rooster. J Biol Chem 1982; 25: 11151-9.
26. Pirenne J, Noizat-Pirenne F, Groote D, et al. Intraoperative cytokines production during orthotopic liver transplantation. Transpl Int 1992; 5: S631-5.
27. Arranz J, Soriano A, Garcia I, et al. Effect of proinflamatory cytokines (IL-6, TNE-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc 2003; 35: 1884-7.
28. Kubala L, Ciz M, Vondracek J, et al. Peri- and post-operative course of cytokines and the metabolic activity of neutrophils in human liver transplantation. Cytokine 2001; 16: 97-101.
29. Asakura T, Ohkohchi N, Satomi S. Changes of serum cytokines associated with hepatic regeneration after living-related liver transplantation. Transplant Proc 2000; 32: 2199-203.
30. Skretting G, Gjernes E, Prydz H. Regulation of lecithin: Cholesterol acyltransferase by TGF-β and Interleukin-6. Biochim Biophys Acta 1995; 1255: 267-72.
31. Zuckerman SH, O'Neal L. Endotoxin and GM-CSF mediated down-regulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody. J Leukoc Biol 1994; 55: 743-8.